Studies have suggested that gut microbial dysbiosis and its related metabolites can stimulate GLP-1 secretion through the GPR41/43 pathway and ultimately lead to the accumulation of fat, which leads to NAFLD (69). The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.